Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 2]
Phase 2 clinical trial evaluating low-dose baricitinib plus danazol for steroid-resistant or relapsed immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Immune Thrombocytopenia Management in Adults [Phase 4]
Phase 4 clinical trial update on management strategies for immune thrombocytopenia in adults.
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia [Phase 3]
An extension study of herombopag in pediatric patients with chronic immune thrombocytopenia is being conducted (Phase 3).
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of orelabrutinib in adults with primary immune thrombocytopenia is underway, wit…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: IVIg Plus Low Dose rhTPO for ITP in Pregnancy [Phase 2]
Phase 2 trial investigating intravenous immunoglobulin plus low-dose recombinant human thrombopoietin for immune thrombocytopenia in pregnan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia [Phase 3]
Phase 3 trial evaluating efficacy and safety of QL0911 in adults with chronic primary immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate [Phase 3]
Phase 3 trial comparing standard steroid treatment to combined steroid & mycophenolate for newly diagnosed immune thrombocytopenia has compl…
-
CLINICAL_TRIALS trial_result · 2022-10-05Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP) [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of LIV-GAMMA SN Inj.10% for immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 2]
Phase 2 clinical trial evaluating baricitinib for steroid-resistant/relapse immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia [Phase 2]
Phase 2 trial exploring terbutaline combined with danazol for corticosteroid-resistant or relapsed immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 2]
Phase 2 trial exploring tacrolimus in combination with danazol for steroid-resistant/relapsed immune thrombocytopenia. Status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia [Phase 2]
Phase 2 trial investigating combined steroid and cyclosporin as first-line treatment for adults with immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia [Phase 2]
Phase 2 study investigating zanubrutinib combined with eltrombopag as second-line therapy in adults with immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 2]
Phase 2 trial evaluating the combination of iguratimod and danazol for steroid-resistant or relapsed immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 2]
Phase 2 trial evaluating the combination of sitagliptin and danazol for steroid-resistant/relapse immune thrombocytopenia; current status un…
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Herombopag + rhTPO in Severe Immune Thrombocytopenia [Phase 3]
Phase 3 trial update for Herombopag plus rhTPO in severe immune thrombocytopenia is reported with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy [Phase 2]
Phase 2 clinical trial investigating prednisone plus recombinant human thrombopoietin for immune thrombocytopenia in pregnancy; status curre…
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Anti-BCMA CAR T-Cell Therapy for R/R ITP [Phase 2]
Phase 2 clinical trial update evaluating anti-BCMA CAR T-cell therapy for relapsed/refractory immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients [Phase 4]
Phase 4 trial update evaluating efficacy and safety of TPO receptor agonists in elderly patients with primary immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 2]
Phase 2 clinical trial update evaluating efficacy and safety of iguratimod in steroid-resistant/relapsed immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: A Study of Orelabrutinib in Patients With ITP [Phase 1, Phase 2]
Clinical trial update for orelabrutinib in immune thrombocytopenia (ITP) across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia [Phase 2]
Phase 2 trial update evaluating the combination of ATRA and high-dose dexamethasone as first-line treatment for adult immune thrombocytopeni…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Atorvastatin in Management of Newly Diagnosed ITP [Phase 2, Phase 3]
Clinical trial update on atorvastatin for management of newly diagnosed immune thrombocytopenia (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP [Phase 2]
Phase 2 clinical trial investigating orelabrutinib for refractory immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia [Phase 2]
Phase 2 clinical trial of eltrombopag in second-line adult primary immune thrombocytopenia has completed.